|
|
Name: |
Propel Bio Management LLC |
City: |
Los Angeles |
State: |
CA |
Zip: |
90067 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
21 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
PAGP |
Plains Gp Holdings Lp |
1 |
- |
$19.54 |
$27,178,000 |
1,272,360 |
31.58% |
3,792,000 |
0 |
0.691 |
Oil & Gas Pipelines &... |
|
MDGL |
Madrigal Pharmaceuticals Inc |
2 |
- |
$298.87 |
$9,947,000 |
30,032 |
11.56% |
-3,331,000 |
-13,000 |
0.117 |
Diagnostic Substances |
|
AKRO |
Akero Therapeutics, Inc. |
3 |
- |
$0.00 |
$9,265,000 |
228,884 |
10.76% |
-298,000 |
-114,845 |
0.303 |
N/A |
|
PHAT |
Phathom Pharmaceuticals, Inc. |
4 |
- |
$0.00 |
$7,116,000 |
1,134,927 |
8.27% |
-922,000 |
145,000 |
1.455 |
N/A |
|
ACHV |
Achieve Life Sciences Inc |
5 |
- |
$2.18 |
$6,550,000 |
2,453,092 |
7.61% |
-2,085,000 |
0 |
7.144 |
Diagnostic Substances |
|
APLT |
Applied Therapeutics Inc. |
6 |
- |
$0.00 |
$5,517,000 |
11,285,420 |
6.41% |
-2,716,000 |
1,670,000 |
9.826 |
N/A |
|
RNA |
Avidity Biosciences, Inc. |
7 |
- |
$29.17 |
$5,269,000 |
178,500 |
6.12% |
78,000 |
0 |
0.132 |
N/A |
|
ABEO |
Abeona Therapeutics Inc |
8 |
- |
$0.19 |
$2,970,000 |
624,022 |
3.45% |
-506,000 |
0 |
0.633 |
Drug Manufacturers - ... |
|
TCRX |
Tscan Therapeutics, Inc. |
9 |
- |
$0.00 |
$2,880,000 |
2,087,139 |
3.35% |
-3,465,000 |
0 |
4.793 |
N/A |
|
DCTH |
Delcath Systems Inc |
10 |
- |
$12.69 |
$2,261,000 |
177,600 |
2.63% |
2,056,000 |
160,600 |
1.162 |
Research Services |
|
SNDX |
Syndax Pharmaceuticals Inc |
11 |
- |
$9.00 |
$2,251,000 |
183,259 |
2.62% |
-172,000 |
0 |
0.195 |
N/A |
|
KMPH |
Kempharm, Inc |
12 |
- |
$9.74 |
$1,347,000 |
179,874 |
1.56% |
-153,000 |
0 |
0.248 |
N/A |
|
MIST |
Milestone Pharmaceuticals Inc. |
13 |
New |
$0.00 |
$1,161,000 |
1,451,557 |
1.35% |
1,161,000 |
1,451,557 |
2.193 |
N/A |
|
CMPX |
Compass Therapeutics Ord Shs |
14 |
New |
$0.00 |
$434,000 |
228,317 |
0.5% |
434,000 |
228,317 |
0.165 |
N/A |
|
ATHA |
Athira Pharma, Inc. |
15 |
- |
$0.00 |
$425,000 |
1,492,792 |
0.49% |
-451,000 |
0 |
4.844 |
N/A |
|
EIGR |
Eiger BioPharmaceuticals Inc |
16 |
- |
$8.50 |
$423,000 |
146,381 |
0.49% |
-342,000 |
0 |
0.45 |
N/A |
|
JSPR |
Jasper Therapeutics Ord Shs |
20 |
Closed |
$15.12 |
$0 |
0 |
0% |
-428,000 |
-20,000 |
0 |
N/A |
|
KURA |
Kura Oncology Inc |
17 |
Closed |
$5.86 |
$0 |
0 |
0% |
-1,132,000 |
-130,000 |
0 |
N/A |
|
ARDX |
Ardelyx Inc |
18 |
Closed |
$4.27 |
$0 |
0 |
0% |
-4,821,000 |
-950,947 |
0 |
N/A |
|
CMPS |
Compass Pathways Plc |
21 |
Closed |
$0.00 |
$0 |
0 |
0% |
-95,000 |
-25,209 |
0 |
N/A |
|
KYMR |
Kymera Therapeutics, Inc. |
19 |
Closed |
$0.00 |
$0 |
0 |
0% |
-2,267,000 |
-56,359 |
0 |
N/A |
|